Medtronic plc (MDT) [Rocket]

In millions, except per share items	Apr-28-23	Apr-29-22	Apr-30-21	Apr-24-20	Apr-26-19	Apr-27-18	Apr-28-17	Apr-29-16
	8-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenues:
Neuroscience		8,784	8,195	7,725	8,183
Diabetes		2,338	2,413	2,368	2,391
Medical Surgical		9,141	8,737	8,352	8,478
Cardiovascular		11,423	10,772	10,468	11,505
Total revenues	31,227	31,686	30,117	28,913	30,557	29,953	29,710	28,833
Revenue growth [+]	-1.4%	5.2%	4.2%	-5.4%	2.0%	0.8%	3.0%	42.3%
Neuroscience		7.2%	6.1%	-5.6%
Diabetes		-3.1%	1.9%	-1.0%
Medical Surgical		4.6%	4.6%	-1.5%
Cardiovascular		6.0%	2.9%	-9.0%
Cardiac and Vascular Group						8.2%	3.0%	8.9%
Cost of goods sold	10,719	10,145	10,483	9,424	9,155	9,067	9,294	9,142
Gross profit	20,508	21,541	19,634	19,489	21,402	20,886	20,416	19,691
Gross margin	65.7%	68.0%	65.2%	67.4%	70.0%	69.7%	68.7%	68.3%
Selling, general and administrative	10,415	10,292	10,148	10,109	10,418	10,238	10,018	9,469
Research and development	2,696	2,746	2,493	2,331	2,330	2,256	2,193	2,224
Other operating expenses	1,537	958	433	384	424	1,293	539	2,347
EBITDA [+]		8,519	7,479	7,572	9,125	7,920	8,603	8,471
EBITDA growth	-31.2%	13.9%	-1.2%	-17.0%	15.2%	-7.9%	1.6%	59.6%
EBITDA margin	18.8%	26.9%	24.8%	26.2%	29.9%	26.4%	29.0%	29.4%
Depreciation and amortization		974	919	907	895	821	937	889
EBITA	5,860	7,545	6,560	6,665	8,230	7,099	7,666	7,582
EBITA margin	18.8%	23.8%	21.8%	23.1%	26.9%	23.7%	25.8%	26.3%
Amortization of intangibles		1,733	1,783	1,756	1,764	1,823	1,980	1,931
EBIT [+]	5,860	5,812	4,777	4,909	6,466	5,276	5,686	5,651
EBIT growth	0.8%	21.7%	-2.7%	-24.1%	22.6%	-7.2%	0.6%	41.2%
EBIT margin	18.8%	18.3%	15.9%	17.0%	21.2%	17.6%	19.1%	19.6%
Non-recurring items [+]	375	60	293	118	198	-1,364	303	290
Loss (gain) on sale of assets						-697
Loss (gain) on sale of business						-697
Interest expense, net [+]	636	553	925	1,092	1,444	1,146	1,094	955
Interest expense	636	553	925	1,092	1,444	1,146	1,094	1,386
Interest income								431
Other income (expense), net	515	318	336	356	373	181	313	-70
Pre-tax income	5,364	5,517	3,895	4,055	5,197	5,675	4,602	4,336
Income taxes	1,580	456	265	-751	547	2,580	578	798
Tax rate	29.5%	8.3%	6.8%		10.5%	45.5%	12.6%	18.4%
Minority interest	-26	-22	24	17	19	-9	-4
Net income	3,784	5,084	3,606	4,789	4,631	3,104	4,028	3,538
Net margin	12.1%	16.0%	12.0%	16.6%	15.2%	10.4%	13.6%	12.3%

Basic EPS [+]	$2.85	$3.79	$2.68	$3.57	$3.44	$2.29	$2.92	$2.51
Growth	-24.9%	41.2%	-24.9%	3.9%	50.3%	-21.7%	16.4%	2.8%
Diluted EPS [+]	$2.84	$3.76	$2.66	$3.54	$3.41	$2.27	$2.89	$2.48
Growth	-24.5%	41.3%	-24.9%	3.9%	50.4%	-21.6%	16.7%	2.9%

Dividends per share [+]		$2.52	$2.32	$2.16	$2.00	$1.84	$1.72	$1.52
Growth	-100.0%	8.6%	7.4%	8.0%	8.7%	7.0%	13.2%	24.6%

Shares outstanding (basic) [+]	1,330	1,342	1,345	1,341	1,346	1,357	1,379	1,410
Growth	-0.9%	-0.2%	0.3%	-0.4%	-0.8%	-1.6%	-2.2%	28.7%
Shares outstanding (diluted) [+]	1,333	1,351	1,354	1,351	1,358	1,368	1,391	1,426
Growth	-1.4%	-0.2%	0.2%	-0.5%	-0.8%	-1.7%	-2.4%	28.6%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.